Accolade ACCD 深 滬
已收盤 04-08 16:00:00 美东时间
7.02
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 7.02
- 總市值 5.76亿
- 52周最高 9.67
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.08
- 委 比 0.00%
- 總股本 8199.31万
- 歷史最高 65.25
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.08
- 每 手 1
- 風險率 0.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ACCO GROUP HOLDINGS LIMITED ANNOUNCES PARTIAL EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTION
ACCO Group Holdings Limited, a corporate service provider based in Hong Kong, announced the partial exercise of the over-allotment option by underwriters, resulting in the sale of an additional 49,900 ordinary shares at US$4.00 each. The total shares sold in the Offering increased to 1,449,900, raising approximately US$5.80 million. The net proceeds will be used for expanding the corporate service business, integrating generative AI, establishing...
2025-11-19 21:15
Accolade Completes Merger, Plans Nasdaq Delisting
An update from Accolade ( ($ACCD) ) is now available. Accolade has announced th...
2025-04-08 22:14
Accolade Announces That Stockholders Voted To Approve Merger With Transcarent
Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the "Special Meeting") held earlier today. The final, certified
2025-03-28 04:10
Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions SEATTLE, March 6, 2025 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) h...
2025-03-06 22:00
Stephens & Co. Reiterates Equal-Weight on Accolade, Maintains $7.03 Price Target
Stephens & Co. analyst Jeff Garro reiterates Accolade (NASDAQ:ACCD) with a Equal-Weight and maintains $7.03 price target.
2025-02-12 23:15
美股大行评级 | 潜在涨幅71%！阿里巴巴获花旗上调目标价至138美元，维持“买入”评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1084758333929132032.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Inozyme Pharma(INZY)"买入"评级，目标价从14美元升至16美元</p> <p>• Maxim Group：上调Reviva Pharmaceutica
2025-01-13 09:38
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Accolade
NEW YORK, Jan. 10, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potent...
2025-01-11 09:24
Accolade Q3 Earnings Assessment
Accolade (NASDAQ:ACCD) released its Q3 earnings on Friday, January 10, 2025 at ...
2025-01-11 05:35
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ACCD, SHOT, POAI, FUBO on Behalf of Shareholders
NEW YORK, Jan. 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2025-01-10 03:50
